USE OF SAFETY-MODIFIED RETROVIRUSES TO INTRODUCE CHEMOTHERAPY RESISTANCE SEQUENCES INTO NORMAL HEMATOPOIETIC-CELLS FOR CHEMOPROTECTION DURING THE THERAPY OF BREAST-CANCER - A PILOT TRIAL

Authors
DEISSEROTH AB HOLMES F HORTOBAGYI G CHAMPLIN R
Citation
Ab. Deisseroth et al., USE OF SAFETY-MODIFIED RETROVIRUSES TO INTRODUCE CHEMOTHERAPY RESISTANCE SEQUENCES INTO NORMAL HEMATOPOIETIC-CELLS FOR CHEMOPROTECTION DURING THE THERAPY OF BREAST-CANCER - A PILOT TRIAL, Human gene therapy, 7(3), 1996, pp. 401-416
Citations number
19
Categorie Soggetti
Genetics & Heredity
Journal title
Human gene therapy → ACNP
ISSN journal
10430342
Volume
7
Issue
3
Year of publication
1996
Pages
401 - 416
Database
ISI
SICI code
1043-0342(1996)7:3<401:UOSRTI>2.0.ZU;2-9